Related Experiment Video
Updated: May 13, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling
1Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA.
Abstract:
The taxanes are effective microtubule-stabilizing chemotherapy drugs used in the treatment of various solid tumors. However, the emergence of drug resistance hampers their clinical efficacy. The molecular basis of clinical taxane resistance remains poorly understood. Breast cancer 1, early onset gene, BRCA1, is a tumor-suppressor gene, whose expression has been correlated with taxane sensitivity in many solid tumors including non-small cell lung cancer. However, the molecular mechanism underlying the relationship between BRCA1 (B1) expression and taxane activity remains unclear. To this end, we created a stable B1 knockdown A549 cell line (B1-KD) to investigate B1's role in microtubule biology and response to taxane treatment. We show that B1-KD rendered A549 cells resistant to paclitaxel (PTX), phenocopying clinical studies showing that low B1 expression correlated with taxane resistance. As previously reported, we show that loss of B1 enhanced centrosomal γ-tubulin localization and microtubule nucleation. Interestingly, we found that the B1-KD cells exhibited increased microtubule dynamics as compared with parental A549 cells, as assessed by live-cell confocal microscopy using enhanced green fluorescent protein-tagged α-tubulin or EB1 protein. In addition, we showed that loss of B1 impairs the ability of PTX to induce microtubule polymerization using immunofluorescence microscopy and a cell-based tubulin polymerization assay. Furthermore, B1-KD cells exhibited significantly lower intracellular binding of a fluorescently labeled PTX to microtubules. Recent studies have shown that PTX-stabilized microtubules serves as a scaffold for pro-caspase-8 binding and induction of apoptosis downstream of induced-proximity activation of caspase-8. Here we show that loss of B1 reduces the association of pro-caspase-8 with microtubules and subsequently leads to impaired PTX-induced activation of apoptosis. Taken together, our data show that B1 regulates indirectly endogenous microtubule dynamics and stability while its loss leads to microtubules that are more dynamic and less susceptible to PTX-induced stabilization conferring taxane resistance.
Insights
Breast cancer gene 1 (BRCA1) loss increases microtubule dynamics, reducing paclitaxel (PTX) efficacy in cancer cells. This BRCA1 knockdown confers taxane resistance by impairing PTX-induced microtubule stabilization and apoptosis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Taxanes are crucial chemotherapy drugs, but drug resistance limits their effectiveness.
- The molecular mechanisms of taxane resistance are not fully understood.
- BRCA1 expression correlates with taxane sensitivity, but its role is unclear.
Purpose of the Study:
- To investigate the role of BRCA1 in microtubule dynamics and response to taxane treatment.
- To elucidate the molecular mechanisms linking BRCA1 expression to taxane resistance.
Main Methods:
- Created a stable BRCA1 knockdown A549 cell line (B1-KD).
- Assessed microtubule dynamics using live-cell confocal microscopy with fluorescently tagged tubulin and EB1.
- Evaluated paclitaxel (PTX) efficacy using immunofluorescence microscopy and tubulin polymerization assays.
- Measured PTX binding to microtubules and pro-caspase-8 association.
Main Results:
- BRCA1 knockdown (B1-KD) conferred resistance to paclitaxel (PTX).
- B1-KD cells showed increased microtubule dynamics and impaired PTX-induced microtubule polymerization.
- Loss of BRCA1 reduced PTX binding to microtubules and pro-caspase-8 association with microtubules.
- BRCA1 loss led to impaired PTX-induced apoptosis.
Conclusions:
- BRCA1 indirectly regulates microtubule dynamics and stability.
- Loss of BRCA1 results in more dynamic microtubules, less susceptible to PTX stabilization.
- BRCA1 deficiency contributes to taxane resistance by altering microtubule properties and apoptotic signaling.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules
Destabilization of Microtubules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

